(Q45876708)

17 December 2017

title

Treatment of bladder cancer cells in vitro and in vivo with 2-5A antisense telomerase RNA. (English)

1 reference

17 December 2017

1 reference

Koga S

1

1 reference

17 December 2017

Kondo Y

series ordinal

2

1 reference

17 December 2017

Komata T

series ordinal

3

1 reference

17 December 2017

Kondo S

series ordinal

4

1 reference

17 December 2017

publication date

1 April 2001

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

8

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

page(s)

654-658

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301449

exact match

0 references

cites work

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

25-year experience in the management of invasive bladder cancer by radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

Telomerase, cell immortality, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

Telomeres and telomerase in aging and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

Specific association of human telomerase activity with immortal cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

Targeting RNA for degradation with a (2'-5')oligoadenylate-antisense chimera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

A novel telomerase-specific gene therapy: gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

Creation of human tumour cells with defined genetic elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

Inhibition of telomerase limits the growth of human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

The RNA component of human telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

Inhibition of human telomerase activity by peptide nucleic acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

A mammalian telomerase-associated protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

Telomerase catalytic subunit homologs from fission yeast and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

Telomere shortening and apoptosis in telomerase-inhibited human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

Crisis intervention: the role of telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

Inhibition of cell-free protein synthesis by pppA2′ p5′ A2′ p5′ A: a novel oligonucleotide synthesized by interferon-treated L cell extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

The Plight of the Patient with Carcinoma in Situ of the Bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

7 January 2021

Prognostic parameters in superficial bladder cancer: an analysis of 315 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

7 January 2021

Telomerase activity in human cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

7 January 2021

Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

7 January 2021

Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301449

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301449

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017